| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.083 | 0.06 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.075 | 0.08 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.055 | 0.2 |